[
  {"condition":"leber congenital amaurosis","approved_product":"Luxturna","agency":"FDA/EMA","approval_year":"2017"},
  {"condition":"acute lymphoblastic leukemia","approved_product":"Kymriah","agency":"FDA/EMA","approval_year":"2017"},
  {"condition":"large b‑cell lymphoma","approved_product":"Yescarta","agency":"FDA/EMA","approval_year":"2017"},
  {"condition":"prostate cancer","approved_product":"Provenge","agency":"FDA","approval_year":"2010"},
  {"condition":"melanoma","approved_product":"Imlygic","agency":"FDA","approval_year":"2015"},
  {"condition":"limbal stem cell deficiency","approved_product":"Holoclar","agency":"EMA","approval_year":"2015"},
  {"condition":"cartilage defects","approved_product":"Spherox","agency":"EMA","approval_year":"2017"},
  {"condition":"perianal fistulas in crohn's disease","approved_product":"Alofisel","agency":"EMA","approval_year":"2018"},
  {"condition":"ada‑scid","approved_product":"Strimvelis","agency":"EMA","approval_year":"2016"},
  {"condition":"hemophilia a","approved_product":"Roctavian","agency":"FDA/EMA","approval_year":"2023"},
  {"condition":"hemophilia b","approved_product":"Beqvez","agency":"FDA/EMA","approval_year":"2024"},
  {"condition":"multiple myeloma","approved_product":"Abecma","agency":"FDA/EMA","approval_year":"2021"},
  {"condition":"diffuse large b‑cell lymphoma","approved_product":"Breyanzi","agency":"FDA","approval_year":"2021"},
  {"condition":"mantle cell lymphoma","approved_product":"Tecartus","agency":"FDA/EMA","approval_year":"2020"},
  {"condition":"type 1 diabetes","approved_product":"Lantidra","agency":"FDA","approval_year":"2023"},
  {"condition":"sickle cell disease","approved_product":"Casgevy","agency":"FDA/EMA","approval_year":"2023"},
  {"condition":"beta thalassemia","approved_product":"Casgevy","agency":"FDA/EMA","approval_year":"2024"},
  {"condition":"recessive dystrophic epidermolysis bullosa","approved_product":"Zevaskyn","agency":"FDA","approval_year":"2025"},
  {"condition":"acdc deficiency (aadcd)","approved_product":"Upstaza","agency":"EMA","approval_year":"2022"},
  {"condition":"spinal muscular atrophy","approved_product":"Zolgensma","agency":"FDA","approval_year":"2019"},
  {"condition":"cartilage defects (knee)","approved_product":"MaxiCart","agency":"EMA","approval_year":"2013"},
  {"condition":"lipo protein lipase deficiency","approved_product":"Glybera","agency":"EMA","approval_year":"2012"},
  {"condition":"hematopoietic stem cell transplant","approved_product":"HemaCord","agency":"FDA","approval_year":"2011"},
  {"condition":"cartilage defects (knee)","approved_product":"ChondroCelect","agency":"EMA","approval_year":"2009"},
  {"condition":"rh confirmed mult myeloma","approved_product":"Carvykti","agency":"FDA/EMA","approval_year":"2022"},
  {"condition":"synovial sarcoma","approved_product":"Tecelra","agency":"FDA","approval_year":"2024"},
  {"condition":"macular telangiectasia type 2","approved_product":"Encelto","agency":"FDA","approval_year":"2025"},
  {"condition":"adenocarcinoma bladder","approved_product":"Adstiladrin","agency":"FDA","approval_year":"2022"},
  {"condition":"prostate cancer","approved_product":"Organogene GINTUIT","agency":"FDA","approval_year":"2012"},
  {"condition":"bladder cancer", "approved_product":"Alofisel", "agency":"EMA", "approval_year":"2018"}
]
